Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability

MLA

Charlotte Welinder, et al. “Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability.” Clinical and Translational Medicine, vol. 2, no. 1, Dec. 2013. EBSCOhost, https://doi.org/10.1186/2001-1326-2-7.

APA

Charlotte Welinder, Göran Jönsson, Christian Ingvar, Lotta Lundgren, Håkan Olsson, Thomas Breslin, Ákos Végvári, Thomas Laurell, Melinda Rezeli, Bo Jansson, Bo Baldetorp, & György Marko‐Varga. (2013). Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability. Clinical and Translational Medicine, 2(1). https://doi.org/10.1186/2001-1326-2-7

Chicago

Charlotte Welinder, Göran Jönsson, Christian Ingvar, Lotta Lundgren, Håkan Olsson, Thomas Breslin, Ákos Végvári, et al. 2013. “Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability.” Clinical and Translational Medicine 2 (1). doi:10.1186/2001-1326-2-7.